X
Search Filters
Format Format
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
ophthalmology (43) 43
index medicus (32) 32
humans (22) 22
female (14) 14
male (14) 14
middle aged (13) 13
der interessante fall (12) 12
aged (10) 10
treatment outcome (10) 10
retina (9) 9
ranibizumab (8) 8
übersicht (8) 8
adult (7) 7
analysis (7) 7
intravitreal injections (7) 7
retinal diseases (7) 7
visual acuity - physiology (7) 7
medicine & public health (6) 6
tomography, optical coherence (6) 6
abridged index medicus (5) 5
aged, 80 and over (5) 5
angiogenesis inhibitors - therapeutic use (5) 5
electrotherapy (5) 5
follow-up studies (5) 5
human necessities (5) 5
hygiene (5) 5
magnetotherapy (5) 5
medical or veterinary science (5) 5
radiation therapy (5) 5
surgery (5) 5
ultrasound therapy (5) 5
vascular endothelial growth factor a - antagonists & inhibitors (5) 5
animals (4) 4
combined modality therapy (4) 4
degeneration (4) 4
eye (4) 4
fluorescein angiography (4) 4
klinische studie (4) 4
laser coagulation (4) 4
macular edema - physiopathology (4) 4
outcomes (4) 4
retinal vein occlusion - drug therapy (4) 4
retinopathy (4) 4
retrospective studies (4) 4
review (4) 4
vitrectomy (4) 4
adolescent (3) 3
anti-vegf (3) 3
antibodies, monoclonal, humanized - therapeutic use (3) 3
clinical trials (3) 3
complications (3) 3
cornea (3) 3
diabetes (3) 3
diabetic retinopathy (3) 3
drug therapy (3) 3
genetic structures (3) 3
injections (3) 3
macula (3) 3
macular degeneration (3) 3
macular edema (3) 3
macular edema - drug therapy (3) 3
prospective studies (3) 3
retinal detachment (3) 3
retinal vein occlusion - physiopathology (3) 3
retreatment (3) 3
safety (3) 3
swine (3) 3
therapy (3) 3
visual acuity (3) 3
12-month outcomes (2) 2
age related macular degeneration (2) 2
age-related macular degeneration (2) 2
amd (2) 2
angiogenesis inhibitors - administration & dosage (2) 2
angiogenesis inhibitors - adverse effects (2) 2
anterior uveitis (2) 2
bandages, dressings or absorbent pads (2) 2
bevacizumab (2) 2
care and treatment (2) 2
child (2) 2
child, preschool (2) 2
choroidal neovascularization (2) 2
cidofovir (2) 2
clinical neurology (2) 2
cytomegalovirus retinitis (2) 2
deep learning (2) 2
devices providing patency to, or preventing collapsing of,tubular structures of the body, e.g. stents (2) 2
diabetes mellitus, type 1 - complications (2) 2
diabetes mellitus, type 2 - complications (2) 2
diabetic retinopathy - drug therapy (2) 2
diabetic retinopathy - physiopathology (2) 2
diagnosis (2) 2
double-blind method (2) 2
endothelial growth-factor (2) 2
eye diseases (2) 2
eye enucleation (2) 2
eyes (2) 2
filters implantable into blood vessels (2) 2
first-aid kits (2) 2
fomentation (2) 2
more...
Library Location Library Location
Language Language
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


Graefe's Archive for Clinical and Experimental Ophthalmology, ISSN 0721-832X, 3/2017, Volume 255, Issue 3, pp. 627 - 628
To access, purchase, authenticate, or subscribe to the full-text of this article, please visit this link: http://dx.doi.org/10.1007/s00417-016-3574-9 
Medicine & Public Health | Ophthalmology | OPHTHALMOLOGY | DYE
Journal Article
Klinische Monatsblatter fur Augenheilkunde, 04/2018, Volume 235, Issue 4, p. 369
Recent case reports have indicated that intraocular lenses may be discoloured by systemically or locally applied fluorescein. Since very few data are available... 
Acrylates | Coloring Agents | Fluorescein - adverse effects | Humans | Optical Phenomena | Polymethyl Methacrylate | Lenses, Intraocular | In Vitro Techniques | Polymers | Silicones | Transillumination
Journal Article
Klinische Monatsblatter fur Augenheilkunde, ISSN 0023-2165, 04/2018, Volume 235, Issue 4, pp. 369 - 372
Background Recent case reports have indicated that intraocular lenses may be discoloured by systemically or locally applied fluorescein. Since very few data... 
physiological optics | cataract | biochemistry | pharmacology | OPHTHALMOLOGY | DIGITAL IMAGE-ANALYSIS
Journal Article
Klinische Monatsblatter fur Augenheilkunde, ISSN 0023-2165, 04/2018, Volume 235, Issue 4, pp. 461 - 462
Journal Article
Klinische Monatsblatter fur Augenheilkunde, ISSN 0023-2165, 2017
Journal Article
Klinische Monatsblatter fur Augenheilkunde, 04/2018, Volume 235, Issue 4, p. 461
Journal Article
Klinische Monatsblatter fur Augenheilkunde, 04/2018, Volume 235, Issue 4, pp. 507 - 508
Journal Article
Klinische Monatsblatter fur Augenheilkunde, 04/2018, Volume 235, Issue 4, p. 507
Journal Article
Klinische Monatsblatter fur Augenheilkunde, 04/2017, Volume 234, Issue 4, p. 606
Journal Article
Ophthalmology, ISSN 0161-6420, 2016, Volume 123, Issue 6, pp. 1332 - 1344
Purpose To compare the 6-month efficacy and safety profile of an individualized stabilization criteria–driven pro re nata (PRN) regimen of ranibizumab 0.5 mg... 
Ophthalmology | Medical colleges | Retinal diseases | Analysis
Journal Article
Ophthalmology, ISSN 0161-6420, 2016, Volume 123, Issue 5, pp. 1101 - 1111
Purpose To assess the 12-month efficacy and safety profile of an individualized regimen of ranibizumab 0.5 mg driven by stabilization criteria in patients with... 
Ophthalmology | TRIAL | VISUAL-ACUITY | OPHTHALMOLOGY | DIABETIC MACULAR EDEMA | INJECTIONS | SUBGROUP ANALYSIS | OUTCOMES | INTRAVITREAL AFLIBERCEPT | DEGENERATION | Medical colleges | Retinal diseases | Analysis
Journal Article
Klinische Monatsblatter fur Augenheilkunde, ISSN 0023-2165, 04/2017, Volume 234, Issue 4, pp. 483 - 486
Background The current standard treatment of choroidal neovascularisation (CNV) secondary to pathological myopia (PM) is intravitreal injection of VEGF... 
anti-VEGF | pathological myopia | choroidal neovascularisation | ranibizumab | PHOTODYNAMIC THERAPY | GROWTH-FACTOR THERAPY | OPHTHALMOLOGY | TERM-FOLLOW-UP | INTRAVITREAL BEVACIZUMAB | CHOROIDAL NEOVASCULARIZATION SECONDARY
Journal Article
Klinische Monatsblatter fur Augenheilkunde, ISSN 0023-2165, 04/2016, Volume 233, Issue 4, pp. 453 - 455
Background: Intravitreal injection of ocriplasmin for the enzymatic resolution of vitreomacular traction was approved for the EU in 2013. We wish to report our... 
adverse effects | Jetrea | Ocriplasmin | vision loss | subfoveal fluid | SYMPTOMATIC VITREOMACULAR ADHESION | TRACTION | INTRAVITREAL OCRIPLASMIN | OPHTHALMOLOGY
Journal Article
Klinische Monatsblatter fur Augenheilkunde, ISSN 0023-2165, 04/2017, Volume 234, Issue 4, pp. 527 - 529
Journal Article
Klinische Monatsblatter fur Augenheilkunde, 04/2019, Volume 236, Issue 4, p. 587
Journal Article
Klinische Monatsblatter fur Augenheilkunde, 04/2019, Volume 236, Issue 4, p. 391
It was the aim of this study to analyse the refractive outcome of toric intraocular lens (t-IOL) implantation guided by a newly developed method of... 
Journal Article
Journal Article
Klinische Monatsblatter fur Augenheilkunde, ISSN 0023-2165, 04/2016, Volume 233, Issue 4, pp. 373 - 374
Journal Article
No results were found for your search.

Cannot display more than 1000 results, please narrow the terms of your search.